Press Releases
AHMEDABAD, India, March 5, 2020 /PRNewswire/ -- Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) NASH ranks as one of the major causes of cirrhosis, behind hepatitis C and alcoholic liver disease and is a leading cause of l
Read more...COLUMBIA, S.C., March 5, 2020 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, suicide is the tenth leading cause of death in the United States and the eleventh leading cause of death in South Carolina. On Wednesday, March 11
Read more...Aspen Surgical Products, Inc., a leader in surgical disposable products, announced the acquisition of Precept Medical Products (“Precept”). Precept designs, manufactures, and markets nonwoven, single-use disposable protective medical apparel that addresses infection control challenges faced by healthcare professionals, with a strong emphasis on the U.S. market. The Arden, North Carolina based company is a leader in the U.S. surgical face mask market with its high-quality
Read more...As parts of the world prepare to reopen during the coronavirus (COVID-19) pandemic, society must reactivate while remaining committed to the health, safety and security of global citizens. With that in mind, Parsons Corporation has developed an integrated, touchless suite of solutions that will monitor real-time health and facilitate the safe movement of people in public areas. The offering – known as DetectWise™ – includes contactless, mobile health screening kios
Read more...Masimo announced the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two methods of intraoperative fluid management during orthopedic spinal surgery, including Masimo PVi®. In comparison to invasive and intermittent central venous pressure (CVP) measurement, noninvasive and continuous pleth variability index (PVi) provided “better cardiac stabilization with less fluid replacement, and more accura
Read more...FX received 510k clearances for their Humeral Cup Stability & Humeral Cup 135/145° Stability for reverse shoulder arthroplasty. The new additional stability cups further enhance an already comprehensive portfolio focused exclusively on shoulder arthroplasty. They provide an immediate option to surgeons for primary, trauma, or revision reverse shoulder arthroplasty to the US market. The stability cup will be offered in all three sizes that FX Solutions [FX Shoulder
Read more...A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients today was approved by the Food and Drug Administration (FDA) for use under the FDA's March 24 ventilator Emergency Use Authorization. Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA's Jet Propulsion Laboratory (JPL) in Southern California to free up the nation's limited supply of traditional v
Read more...Today, Suki, the voice-enabled digital clinical assistant, and QliqSOFT, a leader in patient engagement and virtual care solutions, announced a strategic partnership to empower providers to deliver high-quality, seamless telemedicine. Together, QliqSOFT’s intuitive telemedicine platform will enable providers to offer high-quality virtual visits, while Suki allows them to focus on patients and complete clinical documentation accurately and efficiently. As more and more care shifts to vir
Read more...Hardy Diagnostics, a 100% employee owned, FDA-licensed manufacturer headquartered in Santa Maria, CA, has been exponentially increasing production volume of products needed for testing during the COVID-19 global pandemic. Specifically, Hardy has increased production of Viral Transport Medium (VTM, Cat. No. R99), a product recommended by the CDC for collection and transportation of specimens from patients suspected of a COVID-19 infection. Hardy has increased production volumes from a few hund
Read more...Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test (Cat. No. RTA0203). This immunoassay is intended for qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human plasma or serum. This test was developed by Autobio Diagnostics Co., Ltd (603658, Shanghai), a publicly-traded, major microbiology medical device
Read more...